nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—CYP2B6—Thiotepa—urinary bladder cancer	0.132	0.247	CbGbCtD
Perphenazine—AOX1—Methotrexate—urinary bladder cancer	0.123	0.23	CbGbCtD
Perphenazine—CYP3A4—Thiotepa—urinary bladder cancer	0.0405	0.0759	CbGbCtD
Perphenazine—CYP2B6—Cisplatin—urinary bladder cancer	0.0364	0.0682	CbGbCtD
Perphenazine—CYP2C8—Fluorouracil—urinary bladder cancer	0.0325	0.0608	CbGbCtD
Perphenazine—CYP2C8—Etoposide—urinary bladder cancer	0.0271	0.0507	CbGbCtD
Perphenazine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0251	0.047	CbGbCtD
Perphenazine—CYP2B6—Doxorubicin—urinary bladder cancer	0.0244	0.0457	CbGbCtD
Perphenazine—CYP2C9—Fluorouracil—urinary bladder cancer	0.0226	0.0424	CbGbCtD
Perphenazine—HTR7—vas deferens—urinary bladder cancer	0.0212	0.171	CbGeAlD
Perphenazine—CYP1A2—Etoposide—urinary bladder cancer	0.021	0.0393	CbGbCtD
Perphenazine—CYP2C9—Cisplatin—urinary bladder cancer	0.0192	0.036	CbGbCtD
Perphenazine—CYP2D6—Doxorubicin—urinary bladder cancer	0.0118	0.0221	CbGbCtD
Perphenazine—CYP3A4—Etoposide—urinary bladder cancer	0.011	0.0206	CbGbCtD
Perphenazine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0075	0.014	CbGbCtD
Perphenazine—CYP2C19—urine—urinary bladder cancer	0.00514	0.0415	CbGeAlD
Perphenazine—CYP1A2—urine—urinary bladder cancer	0.0042	0.0339	CbGeAlD
Perphenazine—CYP2C9—urine—urinary bladder cancer	0.00399	0.0322	CbGeAlD
Perphenazine—HTR2A—urine—urinary bladder cancer	0.00328	0.0265	CbGeAlD
Perphenazine—CYP3A4—urine—urinary bladder cancer	0.00304	0.0245	CbGeAlD
Perphenazine—CYP2D6—urine—urinary bladder cancer	0.00299	0.0242	CbGeAlD
Perphenazine—AOX1—prostate gland—urinary bladder cancer	0.00275	0.0222	CbGeAlD
Perphenazine—CALM3—prostate gland—urinary bladder cancer	0.00248	0.02	CbGeAlD
Perphenazine—AOX1—seminal vesicle—urinary bladder cancer	0.00233	0.0188	CbGeAlD
Perphenazine—CYP2C18—vagina—urinary bladder cancer	0.00214	0.0173	CbGeAlD
Perphenazine—CALM3—seminal vesicle—urinary bladder cancer	0.00209	0.0169	CbGeAlD
Perphenazine—CALM2—prostate gland—urinary bladder cancer	0.00194	0.0157	CbGeAlD
Perphenazine—CALM1—prostate gland—urinary bladder cancer	0.00194	0.0156	CbGeAlD
Perphenazine—AOX1—renal system—urinary bladder cancer	0.00187	0.0151	CbGeAlD
Perphenazine—AOX1—urethra—urinary bladder cancer	0.00184	0.0149	CbGeAlD
Perphenazine—CALM3—smooth muscle tissue—urinary bladder cancer	0.00175	0.0142	CbGeAlD
Perphenazine—CALM3—urethra—urinary bladder cancer	0.00166	0.0134	CbGeAlD
Perphenazine—CALM2—seminal vesicle—urinary bladder cancer	0.00164	0.0133	CbGeAlD
Perphenazine—AOX1—female reproductive system—urinary bladder cancer	0.0015	0.0121	CbGeAlD
Perphenazine—CALM2—epithelium—urinary bladder cancer	0.00143	0.0115	CbGeAlD
Perphenazine—CALM1—epithelium—urinary bladder cancer	0.00142	0.0115	CbGeAlD
Perphenazine—HRH1—prostate gland—urinary bladder cancer	0.00141	0.0114	CbGeAlD
Perphenazine—HTR7—epithelium—urinary bladder cancer	0.00139	0.0112	CbGeAlD
Perphenazine—ADRA2A—prostate gland—urinary bladder cancer	0.00139	0.0112	CbGeAlD
Perphenazine—CALM2—smooth muscle tissue—urinary bladder cancer	0.00138	0.0111	CbGeAlD
Perphenazine—CALM1—smooth muscle tissue—urinary bladder cancer	0.00137	0.0111	CbGeAlD
Perphenazine—AOX1—vagina—urinary bladder cancer	0.00136	0.011	CbGeAlD
Perphenazine—HTR1A—renal system—urinary bladder cancer	0.00135	0.0109	CbGeAlD
Perphenazine—HTR7—smooth muscle tissue—urinary bladder cancer	0.00134	0.0108	CbGeAlD
Perphenazine—CALM2—renal system—urinary bladder cancer	0.00133	0.0107	CbGeAlD
Perphenazine—CALM1—renal system—urinary bladder cancer	0.00132	0.0107	CbGeAlD
Perphenazine—CALM2—urethra—urinary bladder cancer	0.0013	0.0105	CbGeAlD
Perphenazine—CALM1—urethra—urinary bladder cancer	0.0013	0.0105	CbGeAlD
Perphenazine—HTR7—renal system—urinary bladder cancer	0.00129	0.0104	CbGeAlD
Perphenazine—HTR2C—female reproductive system—urinary bladder cancer	0.00128	0.0104	CbGeAlD
Perphenazine—CALM3—vagina—urinary bladder cancer	0.00122	0.00987	CbGeAlD
Perphenazine—ADRA2A—seminal vesicle—urinary bladder cancer	0.00117	0.00947	CbGeAlD
Perphenazine—CYP2C8—renal system—urinary bladder cancer	0.0011	0.00887	CbGeAlD
Perphenazine—CALM2—female reproductive system—urinary bladder cancer	0.00106	0.00857	CbGeAlD
Perphenazine—CALM1—female reproductive system—urinary bladder cancer	0.00106	0.00853	CbGeAlD
Perphenazine—HRH1—epithelium—urinary bladder cancer	0.00104	0.00837	CbGeAlD
Perphenazine—HTR7—female reproductive system—urinary bladder cancer	0.00103	0.00833	CbGeAlD
Perphenazine—CYP1A2—renal system—urinary bladder cancer	0.00103	0.0083	CbGeAlD
Perphenazine—HRH1—smooth muscle tissue—urinary bladder cancer	0.000999	0.00807	CbGeAlD
Perphenazine—CYP2B6—renal system—urinary bladder cancer	0.000985	0.00795	CbGeAlD
Perphenazine—CALM2—vagina—urinary bladder cancer	0.00096	0.00775	CbGeAlD
Perphenazine—CALM1—vagina—urinary bladder cancer	0.000955	0.00771	CbGeAlD
Perphenazine—HRH1—urethra—urinary bladder cancer	0.000945	0.00763	CbGeAlD
Perphenazine—ADRA2A—urethra—urinary bladder cancer	0.000928	0.0075	CbGeAlD
Perphenazine—CYP2C19—vagina—urinary bladder cancer	0.000911	0.00736	CbGeAlD
Perphenazine—CYP2C8—female reproductive system—urinary bladder cancer	0.00088	0.0071	CbGeAlD
Perphenazine—AOX1—lymph node—urinary bladder cancer	0.000878	0.00709	CbGeAlD
Perphenazine—HTR2A—epithelium—urinary bladder cancer	0.000866	0.00699	CbGeAlD
Perphenazine—HTR2A—smooth muscle tissue—urinary bladder cancer	0.000835	0.00674	CbGeAlD
Perphenazine—HTR2A—renal system—urinary bladder cancer	0.000804	0.00649	CbGeAlD
Perphenazine—CYP2C8—vagina—urinary bladder cancer	0.000795	0.00642	CbGeAlD
Perphenazine—CALM3—lymph node—urinary bladder cancer	0.000791	0.00638	CbGeAlD
Perphenazine—CYP2B6—female reproductive system—urinary bladder cancer	0.000789	0.00637	CbGeAlD
Perphenazine—CYP2C9—female reproductive system—urinary bladder cancer	0.000781	0.00631	CbGeAlD
Perphenazine—HRH1—female reproductive system—urinary bladder cancer	0.000771	0.00622	CbGeAlD
Perphenazine—ADRA2A—female reproductive system—urinary bladder cancer	0.000757	0.00611	CbGeAlD
Perphenazine—CYP3A4—renal system—urinary bladder cancer	0.000744	0.00601	CbGeAlD
Perphenazine—CYP2D6—renal system—urinary bladder cancer	0.000732	0.00591	CbGeAlD
Perphenazine—CYP2B6—vagina—urinary bladder cancer	0.000714	0.00576	CbGeAlD
Perphenazine—HRH1—vagina—urinary bladder cancer	0.000697	0.00563	CbGeAlD
Perphenazine—ADRA2A—vagina—urinary bladder cancer	0.000684	0.00553	CbGeAlD
Perphenazine—HTR2A—female reproductive system—urinary bladder cancer	0.000644	0.0052	CbGeAlD
Perphenazine—CALM2—lymph node—urinary bladder cancer	0.000621	0.00501	CbGeAlD
Perphenazine—CALM1—lymph node—urinary bladder cancer	0.000618	0.00499	CbGeAlD
Perphenazine—CYP3A4—female reproductive system—urinary bladder cancer	0.000596	0.00481	CbGeAlD
Perphenazine—CYP2D6—female reproductive system—urinary bladder cancer	0.000586	0.00473	CbGeAlD
Perphenazine—HTR2A—vagina—urinary bladder cancer	0.000582	0.0047	CbGeAlD
Perphenazine—Dysarthria—Doxorubicin—urinary bladder cancer	0.000494	0.00286	CcSEcCtD
Perphenazine—Jaundice—Etoposide—urinary bladder cancer	0.000491	0.00284	CcSEcCtD
Perphenazine—Leukopenia—Thiotepa—urinary bladder cancer	0.000491	0.00284	CcSEcCtD
Perphenazine—Salivary hypersecretion—Epirubicin—urinary bladder cancer	0.00049	0.00284	CcSEcCtD
Perphenazine—Urine output increased—Methotrexate—urinary bladder cancer	0.000488	0.00282	CcSEcCtD
Perphenazine—Gynaecomastia—Methotrexate—urinary bladder cancer	0.000483	0.0028	CcSEcCtD
Perphenazine—Cough—Thiotepa—urinary bladder cancer	0.000478	0.00277	CcSEcCtD
Perphenazine—Convulsion—Thiotepa—urinary bladder cancer	0.000475	0.00275	CcSEcCtD
Perphenazine—Hypertension—Thiotepa—urinary bladder cancer	0.000473	0.00274	CcSEcCtD
Perphenazine—Agranulocytosis—Etoposide—urinary bladder cancer	0.00047	0.00272	CcSEcCtD
Perphenazine—Hepatocellular injury—Doxorubicin—urinary bladder cancer	0.000467	0.00271	CcSEcCtD
Perphenazine—Dermatitis contact—Doxorubicin—urinary bladder cancer	0.000462	0.00267	CcSEcCtD
Perphenazine—Abnormal dreams—Doxorubicin—urinary bladder cancer	0.000462	0.00267	CcSEcCtD
Perphenazine—Erythema—Gemcitabine—urinary bladder cancer	0.000461	0.00267	CcSEcCtD
Perphenazine—Salivary hypersecretion—Doxorubicin—urinary bladder cancer	0.000454	0.00263	CcSEcCtD
Perphenazine—Erythema—Fluorouracil—urinary bladder cancer	0.000453	0.00263	CcSEcCtD
Perphenazine—Confusional state—Thiotepa—urinary bladder cancer	0.000451	0.00261	CcSEcCtD
Perphenazine—HRH1—lymph node—urinary bladder cancer	0.000451	0.00364	CbGeAlD
Perphenazine—Hypoaesthesia—Etoposide—urinary bladder cancer	0.00045	0.00261	CcSEcCtD
Perphenazine—Photosensitivity—Methotrexate—urinary bladder cancer	0.000446	0.00258	CcSEcCtD
Perphenazine—Polyuria—Methotrexate—urinary bladder cancer	0.000446	0.00258	CcSEcCtD
Perphenazine—Infection—Thiotepa—urinary bladder cancer	0.000444	0.00257	CcSEcCtD
Perphenazine—ADRA2A—lymph node—urinary bladder cancer	0.000443	0.00357	CbGeAlD
Perphenazine—Tachycardia—Thiotepa—urinary bladder cancer	0.000437	0.00253	CcSEcCtD
Perphenazine—Erythema—Cisplatin—urinary bladder cancer	0.00043	0.00249	CcSEcCtD
Perphenazine—Vision blurred—Fluorouracil—urinary bladder cancer	0.000427	0.00247	CcSEcCtD
Perphenazine—Anorexia—Thiotepa—urinary bladder cancer	0.000426	0.00247	CcSEcCtD
Perphenazine—Photosensitivity—Epirubicin—urinary bladder cancer	0.000417	0.00242	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.000415	0.0024	CcSEcCtD
Perphenazine—Muscle spasms—Cisplatin—urinary bladder cancer	0.000413	0.00239	CcSEcCtD
Perphenazine—Leukopenia—Gemcitabine—urinary bladder cancer	0.000413	0.00239	CcSEcCtD
Perphenazine—Eczema—Epirubicin—urinary bladder cancer	0.000408	0.00236	CcSEcCtD
Perphenazine—Leukopenia—Fluorouracil—urinary bladder cancer	0.000406	0.00235	CcSEcCtD
Perphenazine—Vision blurred—Cisplatin—urinary bladder cancer	0.000405	0.00235	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.000405	0.00234	CcSEcCtD
Perphenazine—Cough—Gemcitabine—urinary bladder cancer	0.000402	0.00233	CcSEcCtD
Perphenazine—Lethargy—Methotrexate—urinary bladder cancer	0.0004	0.00231	CcSEcCtD
Perphenazine—Hypertension—Gemcitabine—urinary bladder cancer	0.000398	0.00231	CcSEcCtD
Perphenazine—Somnolence—Thiotepa—urinary bladder cancer	0.000398	0.0023	CcSEcCtD
Perphenazine—Convulsion—Fluorouracil—urinary bladder cancer	0.000393	0.00227	CcSEcCtD
Perphenazine—Decreased appetite—Thiotepa—urinary bladder cancer	0.000389	0.00225	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.000388	0.00225	CcSEcCtD
Perphenazine—Photosensitivity—Doxorubicin—urinary bladder cancer	0.000386	0.00224	CcSEcCtD
Perphenazine—Leukopenia—Cisplatin—urinary bladder cancer	0.000385	0.00223	CcSEcCtD
Perphenazine—Pain—Thiotepa—urinary bladder cancer	0.000382	0.00222	CcSEcCtD
Perphenazine—Constipation—Thiotepa—urinary bladder cancer	0.000382	0.00222	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.000379	0.00219	CcSEcCtD
Perphenazine—Muscle spasms—Etoposide—urinary bladder cancer	0.000378	0.00219	CcSEcCtD
Perphenazine—Eczema—Doxorubicin—urinary bladder cancer	0.000377	0.00218	CcSEcCtD
Perphenazine—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000376	0.00218	CcSEcCtD
Perphenazine—Hypoglycaemia—Epirubicin—urinary bladder cancer	0.000375	0.00217	CcSEcCtD
Perphenazine—Lethargy—Epirubicin—urinary bladder cancer	0.000374	0.00217	CcSEcCtD
Perphenazine—Infection—Gemcitabine—urinary bladder cancer	0.000374	0.00216	CcSEcCtD
Perphenazine—Confusional state—Fluorouracil—urinary bladder cancer	0.000373	0.00216	CcSEcCtD
Perphenazine—Convulsion—Cisplatin—urinary bladder cancer	0.000372	0.00216	CcSEcCtD
Perphenazine—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00037	0.00214	CcSEcCtD
Perphenazine—Ataxia—Methotrexate—urinary bladder cancer	0.000368	0.00213	CcSEcCtD
Perphenazine—Infection—Fluorouracil—urinary bladder cancer	0.000368	0.00213	CcSEcCtD
Perphenazine—Tachycardia—Fluorouracil—urinary bladder cancer	0.000361	0.00209	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.000359	0.00208	CcSEcCtD
Perphenazine—Anorexia—Gemcitabine—urinary bladder cancer	0.000359	0.00208	CcSEcCtD
Perphenazine—Urticaria—Thiotepa—urinary bladder cancer	0.000355	0.00206	CcSEcCtD
Perphenazine—Body temperature increased—Thiotepa—urinary bladder cancer	0.000354	0.00205	CcSEcCtD
Perphenazine—Anorexia—Fluorouracil—urinary bladder cancer	0.000353	0.00204	CcSEcCtD
Perphenazine—Leukopenia—Etoposide—urinary bladder cancer	0.000352	0.00204	CcSEcCtD
Perphenazine—Hypotension—Gemcitabine—urinary bladder cancer	0.000352	0.00204	CcSEcCtD
Perphenazine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000351	0.00203	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.00035	0.00203	CcSEcCtD
Perphenazine—Cardiac arrest—Epirubicin—urinary bladder cancer	0.000348	0.00202	CcSEcCtD
Perphenazine—Infection—Cisplatin—urinary bladder cancer	0.000348	0.00202	CcSEcCtD
Perphenazine—Hypoglycaemia—Doxorubicin—urinary bladder cancer	0.000347	0.00201	CcSEcCtD
Perphenazine—Loss of consciousness—Etoposide—urinary bladder cancer	0.000346	0.002	CcSEcCtD
Perphenazine—Lethargy—Doxorubicin—urinary bladder cancer	0.000346	0.002	CcSEcCtD
Perphenazine—Hypotension—Fluorouracil—urinary bladder cancer	0.000346	0.002	CcSEcCtD
Perphenazine—Ataxia—Epirubicin—urinary bladder cancer	0.000345	0.002	CcSEcCtD
Perphenazine—Cough—Etoposide—urinary bladder cancer	0.000344	0.00199	CcSEcCtD
Perphenazine—Tachycardia—Cisplatin—urinary bladder cancer	0.000342	0.00198	CcSEcCtD
Perphenazine—Convulsion—Etoposide—urinary bladder cancer	0.000341	0.00198	CcSEcCtD
Perphenazine—Insomnia—Gemcitabine—urinary bladder cancer	0.00034	0.00197	CcSEcCtD
Perphenazine—Hypertension—Etoposide—urinary bladder cancer	0.00034	0.00197	CcSEcCtD
Perphenazine—Asthma—Methotrexate—urinary bladder cancer	0.000338	0.00196	CcSEcCtD
Perphenazine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000335	0.00194	CcSEcCtD
Perphenazine—Eosinophilia—Methotrexate—urinary bladder cancer	0.000335	0.00194	CcSEcCtD
Perphenazine—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.000335	0.00194	CcSEcCtD
Perphenazine—Insomnia—Fluorouracil—urinary bladder cancer	0.000335	0.00194	CcSEcCtD
Perphenazine—Somnolence—Gemcitabine—urinary bladder cancer	0.000334	0.00194	CcSEcCtD
Perphenazine—Anorexia—Cisplatin—urinary bladder cancer	0.000334	0.00194	CcSEcCtD
Perphenazine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00033	0.00191	CcSEcCtD
Perphenazine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00033	0.00191	CcSEcCtD
Perphenazine—Somnolence—Fluorouracil—urinary bladder cancer	0.000329	0.0019	CcSEcCtD
Perphenazine—Hypotension—Cisplatin—urinary bladder cancer	0.000328	0.0019	CcSEcCtD
Perphenazine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000327	0.00189	CcSEcCtD
Perphenazine—Confusional state—Etoposide—urinary bladder cancer	0.000324	0.00188	CcSEcCtD
Perphenazine—Muscular weakness—Epirubicin—urinary bladder cancer	0.000323	0.00187	CcSEcCtD
Perphenazine—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.000322	0.00187	CcSEcCtD
Perphenazine—Pain—Gemcitabine—urinary bladder cancer	0.000322	0.00186	CcSEcCtD
Perphenazine—Constipation—Gemcitabine—urinary bladder cancer	0.000322	0.00186	CcSEcCtD
Perphenazine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000322	0.00186	CcSEcCtD
Perphenazine—Pancytopenia—Methotrexate—urinary bladder cancer	0.000321	0.00186	CcSEcCtD
Perphenazine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000321	0.00186	CcSEcCtD
Perphenazine—Infection—Etoposide—urinary bladder cancer	0.000319	0.00185	CcSEcCtD
Perphenazine—Ataxia—Doxorubicin—urinary bladder cancer	0.000319	0.00185	CcSEcCtD
Perphenazine—Asthma—Epirubicin—urinary bladder cancer	0.000317	0.00183	CcSEcCtD
Perphenazine—Dysphagia—Epirubicin—urinary bladder cancer	0.000317	0.00183	CcSEcCtD
Perphenazine—Pruritus—Thiotepa—urinary bladder cancer	0.000316	0.00183	CcSEcCtD
Perphenazine—Pain—Fluorouracil—urinary bladder cancer	0.000316	0.00183	CcSEcCtD
Perphenazine—Tachycardia—Etoposide—urinary bladder cancer	0.000314	0.00182	CcSEcCtD
Perphenazine—Eosinophilia—Epirubicin—urinary bladder cancer	0.000314	0.00182	CcSEcCtD
Perphenazine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000313	0.00181	CcSEcCtD
Perphenazine—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.00031	0.00179	CcSEcCtD
Perphenazine—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000309	0.00179	CcSEcCtD
Perphenazine—Anorexia—Etoposide—urinary bladder cancer	0.000306	0.00177	CcSEcCtD
Perphenazine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000306	0.00177	CcSEcCtD
Perphenazine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000305	0.00177	CcSEcCtD
Perphenazine—Drowsiness—Methotrexate—urinary bladder cancer	0.000302	0.00175	CcSEcCtD
Perphenazine—Pancytopenia—Epirubicin—urinary bladder cancer	0.000301	0.00174	CcSEcCtD
Perphenazine—Hypotension—Etoposide—urinary bladder cancer	0.0003	0.00174	CcSEcCtD
Perphenazine—Pain—Cisplatin—urinary bladder cancer	0.0003	0.00174	CcSEcCtD
Perphenazine—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000299	0.00173	CcSEcCtD
Perphenazine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000297	0.00172	CcSEcCtD
Perphenazine—Dizziness—Thiotepa—urinary bladder cancer	0.000296	0.00171	CcSEcCtD
Perphenazine—Urticaria—Fluorouracil—urinary bladder cancer	0.000294	0.0017	CcSEcCtD
Perphenazine—Asthma—Doxorubicin—urinary bladder cancer	0.000293	0.0017	CcSEcCtD
Perphenazine—Dysphagia—Doxorubicin—urinary bladder cancer	0.000293	0.0017	CcSEcCtD
Perphenazine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000292	0.00169	CcSEcCtD
Perphenazine—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00029	0.00168	CcSEcCtD
Perphenazine—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000289	0.00167	CcSEcCtD
Perphenazine—Dyspnoea—Etoposide—urinary bladder cancer	0.000286	0.00166	CcSEcCtD
Perphenazine—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000286	0.00165	CcSEcCtD
Perphenazine—Somnolence—Etoposide—urinary bladder cancer	0.000286	0.00165	CcSEcCtD
Perphenazine—Drowsiness—Epirubicin—urinary bladder cancer	0.000282	0.00164	CcSEcCtD
Perphenazine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000282	0.00163	CcSEcCtD
Perphenazine—Headache—Thiotepa—urinary bladder cancer	0.00028	0.00162	CcSEcCtD
Perphenazine—Decreased appetite—Etoposide—urinary bladder cancer	0.000279	0.00162	CcSEcCtD
Perphenazine—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000278	0.00161	CcSEcCtD
Perphenazine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000277	0.00161	CcSEcCtD
Perphenazine—Jaundice—Epirubicin—urinary bladder cancer	0.000275	0.00159	CcSEcCtD
Perphenazine—Pain—Etoposide—urinary bladder cancer	0.000275	0.00159	CcSEcCtD
Perphenazine—Constipation—Etoposide—urinary bladder cancer	0.000275	0.00159	CcSEcCtD
Perphenazine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000273	0.00158	CcSEcCtD
Perphenazine—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000267	0.00155	CcSEcCtD
Perphenazine—Pruritus—Gemcitabine—urinary bladder cancer	0.000266	0.00154	CcSEcCtD
Perphenazine—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000264	0.00153	CcSEcCtD
Perphenazine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000264	0.00153	CcSEcCtD
Perphenazine—Pruritus—Fluorouracil—urinary bladder cancer	0.000262	0.00152	CcSEcCtD
Perphenazine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000261	0.00151	CcSEcCtD
Perphenazine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000258	0.0015	CcSEcCtD
Perphenazine—Bradycardia—Epirubicin—urinary bladder cancer	0.000258	0.00149	CcSEcCtD
Perphenazine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000257	0.00149	CcSEcCtD
Perphenazine—Urticaria—Etoposide—urinary bladder cancer	0.000255	0.00148	CcSEcCtD
Perphenazine—Jaundice—Doxorubicin—urinary bladder cancer	0.000255	0.00147	CcSEcCtD
Perphenazine—Body temperature increased—Etoposide—urinary bladder cancer	0.000254	0.00147	CcSEcCtD
Perphenazine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000253	0.00147	CcSEcCtD
Perphenazine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000252	0.00146	CcSEcCtD
Perphenazine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00025	0.00145	CcSEcCtD
Perphenazine—Dizziness—Fluorouracil—urinary bladder cancer	0.000245	0.00142	CcSEcCtD
Perphenazine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000244	0.00141	CcSEcCtD
Perphenazine—Diarrhoea—Cisplatin—urinary bladder cancer	0.00024	0.00139	CcSEcCtD
Perphenazine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000239	0.00138	CcSEcCtD
Perphenazine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000237	0.00137	CcSEcCtD
Perphenazine—Erythema—Methotrexate—urinary bladder cancer	0.000236	0.00137	CcSEcCtD
Perphenazine—Headache—Gemcitabine—urinary bladder cancer	0.000236	0.00137	CcSEcCtD
Perphenazine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000233	0.00135	CcSEcCtD
Perphenazine—Headache—Fluorouracil—urinary bladder cancer	0.000232	0.00134	CcSEcCtD
Perphenazine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000231	0.00134	CcSEcCtD
Perphenazine—Pruritus—Etoposide—urinary bladder cancer	0.000227	0.00132	CcSEcCtD
Perphenazine—Vision blurred—Methotrexate—urinary bladder cancer	0.000222	0.00129	CcSEcCtD
Perphenazine—Erythema—Epirubicin—urinary bladder cancer	0.000221	0.00128	CcSEcCtD
Perphenazine—Diarrhoea—Etoposide—urinary bladder cancer	0.00022	0.00127	CcSEcCtD
Perphenazine—Dizziness—Etoposide—urinary bladder cancer	0.000212	0.00123	CcSEcCtD
Perphenazine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000212	0.00123	CcSEcCtD
Perphenazine—Leukopenia—Methotrexate—urinary bladder cancer	0.000211	0.00122	CcSEcCtD
Perphenazine—Vision blurred—Epirubicin—urinary bladder cancer	0.000208	0.0012	CcSEcCtD
Perphenazine—Cough—Methotrexate—urinary bladder cancer	0.000206	0.00119	CcSEcCtD
Perphenazine—Convulsion—Methotrexate—urinary bladder cancer	0.000204	0.00118	CcSEcCtD
Perphenazine—Erythema—Doxorubicin—urinary bladder cancer	0.000204	0.00118	CcSEcCtD
Perphenazine—Agitation—Epirubicin—urinary bladder cancer	0.000203	0.00117	CcSEcCtD
Perphenazine—Headache—Etoposide—urinary bladder cancer	0.000201	0.00117	CcSEcCtD
Perphenazine—Syncope—Epirubicin—urinary bladder cancer	0.000198	0.00115	CcSEcCtD
Perphenazine—Leukopenia—Epirubicin—urinary bladder cancer	0.000198	0.00114	CcSEcCtD
Perphenazine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000196	0.00114	CcSEcCtD
Perphenazine—Confusional state—Methotrexate—urinary bladder cancer	0.000194	0.00112	CcSEcCtD
Perphenazine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000194	0.00112	CcSEcCtD
Perphenazine—Cough—Epirubicin—urinary bladder cancer	0.000193	0.00112	CcSEcCtD
Perphenazine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000192	0.00111	CcSEcCtD
Perphenazine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000192	0.00111	CcSEcCtD
Perphenazine—Convulsion—Epirubicin—urinary bladder cancer	0.000191	0.00111	CcSEcCtD
Perphenazine—Infection—Methotrexate—urinary bladder cancer	0.000191	0.00111	CcSEcCtD
Perphenazine—Hypertension—Epirubicin—urinary bladder cancer	0.000191	0.0011	CcSEcCtD
Perphenazine—Agitation—Doxorubicin—urinary bladder cancer	0.000188	0.00109	CcSEcCtD
Perphenazine—Dry mouth—Epirubicin—urinary bladder cancer	0.000184	0.00106	CcSEcCtD
Perphenazine—Anorexia—Methotrexate—urinary bladder cancer	0.000183	0.00106	CcSEcCtD
Perphenazine—Syncope—Doxorubicin—urinary bladder cancer	0.000183	0.00106	CcSEcCtD
Perphenazine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000183	0.00106	CcSEcCtD
Perphenazine—Confusional state—Epirubicin—urinary bladder cancer	0.000182	0.00105	CcSEcCtD
Perphenazine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00018	0.00104	CcSEcCtD
Perphenazine—Hypotension—Methotrexate—urinary bladder cancer	0.00018	0.00104	CcSEcCtD
Perphenazine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000179	0.00104	CcSEcCtD
Perphenazine—Infection—Epirubicin—urinary bladder cancer	0.000179	0.00104	CcSEcCtD
Perphenazine—Cough—Doxorubicin—urinary bladder cancer	0.000178	0.00103	CcSEcCtD
Perphenazine—Shock—Epirubicin—urinary bladder cancer	0.000177	0.00103	CcSEcCtD
Perphenazine—Convulsion—Doxorubicin—urinary bladder cancer	0.000177	0.00102	CcSEcCtD
Perphenazine—Hypertension—Doxorubicin—urinary bladder cancer	0.000176	0.00102	CcSEcCtD
Perphenazine—Tachycardia—Epirubicin—urinary bladder cancer	0.000176	0.00102	CcSEcCtD
Perphenazine—Insomnia—Methotrexate—urinary bladder cancer	0.000174	0.00101	CcSEcCtD
Perphenazine—Anorexia—Epirubicin—urinary bladder cancer	0.000172	0.000994	CcSEcCtD
Perphenazine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000172	0.000994	CcSEcCtD
Perphenazine—Somnolence—Methotrexate—urinary bladder cancer	0.000171	0.000991	CcSEcCtD
Perphenazine—Dry mouth—Doxorubicin—urinary bladder cancer	0.00017	0.000985	CcSEcCtD
Perphenazine—Hypotension—Epirubicin—urinary bladder cancer	0.000168	0.000975	CcSEcCtD
Perphenazine—Confusional state—Doxorubicin—urinary bladder cancer	0.000168	0.000973	CcSEcCtD
Perphenazine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000167	0.000969	CcSEcCtD
Perphenazine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000167	0.000965	CcSEcCtD
Perphenazine—Infection—Doxorubicin—urinary bladder cancer	0.000166	0.000959	CcSEcCtD
Perphenazine—Pain—Methotrexate—urinary bladder cancer	0.000165	0.000953	CcSEcCtD
Perphenazine—Shock—Doxorubicin—urinary bladder cancer	0.000164	0.000949	CcSEcCtD
Perphenazine—Insomnia—Epirubicin—urinary bladder cancer	0.000163	0.000943	CcSEcCtD
Perphenazine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000163	0.000942	CcSEcCtD
Perphenazine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000161	0.00093	CcSEcCtD
Perphenazine—Somnolence—Epirubicin—urinary bladder cancer	0.00016	0.000927	CcSEcCtD
Perphenazine—Anorexia—Doxorubicin—urinary bladder cancer	0.000159	0.00092	CcSEcCtD
Perphenazine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000157	0.000907	CcSEcCtD
Perphenazine—Hypotension—Doxorubicin—urinary bladder cancer	0.000156	0.000902	CcSEcCtD
Perphenazine—Constipation—Epirubicin—urinary bladder cancer	0.000154	0.000892	CcSEcCtD
Perphenazine—Pain—Epirubicin—urinary bladder cancer	0.000154	0.000892	CcSEcCtD
Perphenazine—Urticaria—Methotrexate—urinary bladder cancer	0.000153	0.000885	CcSEcCtD
Perphenazine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000152	0.000881	CcSEcCtD
Perphenazine—Insomnia—Doxorubicin—urinary bladder cancer	0.000151	0.000873	CcSEcCtD
Perphenazine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000149	0.00086	CcSEcCtD
Perphenazine—Somnolence—Doxorubicin—urinary bladder cancer	0.000148	0.000858	CcSEcCtD
Perphenazine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000145	0.000839	CcSEcCtD
Perphenazine—Urticaria—Epirubicin—urinary bladder cancer	0.000143	0.000829	CcSEcCtD
Perphenazine—Constipation—Doxorubicin—urinary bladder cancer	0.000143	0.000825	CcSEcCtD
Perphenazine—Pain—Doxorubicin—urinary bladder cancer	0.000143	0.000825	CcSEcCtD
Perphenazine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000142	0.000825	CcSEcCtD
Perphenazine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000142	0.000821	CcSEcCtD
Perphenazine—Pruritus—Methotrexate—urinary bladder cancer	0.000136	0.000789	CcSEcCtD
Perphenazine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000133	0.000768	CcSEcCtD
Perphenazine—Urticaria—Doxorubicin—urinary bladder cancer	0.000132	0.000767	CcSEcCtD
Perphenazine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000132	0.000763	CcSEcCtD
Perphenazine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000132	0.000763	CcSEcCtD
Perphenazine—Pruritus—Epirubicin—urinary bladder cancer	0.000127	0.000738	CcSEcCtD
Perphenazine—Dizziness—Methotrexate—urinary bladder cancer	0.000127	0.000737	CcSEcCtD
Perphenazine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000123	0.000714	CcSEcCtD
Perphenazine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000123	0.000711	CcSEcCtD
Perphenazine—Headache—Methotrexate—urinary bladder cancer	0.000121	0.000698	CcSEcCtD
Perphenazine—Dizziness—Epirubicin—urinary bladder cancer	0.000119	0.00069	CcSEcCtD
Perphenazine—Pruritus—Doxorubicin—urinary bladder cancer	0.000118	0.000683	CcSEcCtD
Perphenazine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000114	0.00066	CcSEcCtD
Perphenazine—Headache—Epirubicin—urinary bladder cancer	0.000113	0.000653	CcSEcCtD
Perphenazine—Dizziness—Doxorubicin—urinary bladder cancer	0.00011	0.000638	CcSEcCtD
Perphenazine—Headache—Doxorubicin—urinary bladder cancer	0.000104	0.000605	CcSEcCtD
Perphenazine—CALM3—Immune System—EP300—urinary bladder cancer	8.94e-06	5.29e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL2—urinary bladder cancer	8.94e-06	5.29e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	8.92e-06	5.28e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	8.92e-06	5.28e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	8.83e-06	5.22e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—KRAS—urinary bladder cancer	8.77e-06	5.19e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—KRAS—urinary bladder cancer	8.76e-06	5.18e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CCND1—urinary bladder cancer	8.76e-06	5.18e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CCND1—urinary bladder cancer	8.71e-06	5.15e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—ERBB2—urinary bladder cancer	8.71e-06	5.15e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—SRC—urinary bladder cancer	8.7e-06	5.14e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—CDKN1A—urinary bladder cancer	8.68e-06	5.13e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—PTEN—urinary bladder cancer	8.66e-06	5.12e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—EP300—urinary bladder cancer	8.65e-06	5.11e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—EP300—urinary bladder cancer	8.65e-06	5.11e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—KRAS—urinary bladder cancer	8.64e-06	5.11e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—ERBB2—urinary bladder cancer	8.57e-06	5.06e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—ERBB2—urinary bladder cancer	8.55e-06	5.05e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	8.55e-06	5.05e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	8.54e-06	5.05e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MMP9—urinary bladder cancer	8.5e-06	5.03e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CREBBP—urinary bladder cancer	8.49e-06	5.02e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CDKN1A—urinary bladder cancer	8.47e-06	5.01e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MMP9—urinary bladder cancer	8.46e-06	5e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—PTEN—urinary bladder cancer	8.45e-06	5e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CDKN1A—urinary bladder cancer	8.43e-06	4.98e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—RHOA—urinary bladder cancer	8.42e-06	4.98e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—SRC—urinary bladder cancer	8.41e-06	4.97e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—SRC—urinary bladder cancer	8.41e-06	4.97e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—PTEN—urinary bladder cancer	8.41e-06	4.97e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—CDKN1A—urinary bladder cancer	8.39e-06	4.96e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—CDKN1A—urinary bladder cancer	8.39e-06	4.96e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	8.39e-06	4.96e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IGF1—urinary bladder cancer	8.38e-06	4.96e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—PTEN—urinary bladder cancer	8.38e-06	4.95e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—PTEN—urinary bladder cancer	8.38e-06	4.95e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—EGFR—urinary bladder cancer	8.34e-06	4.93e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PTGS2—urinary bladder cancer	8.31e-06	4.92e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—EP300—urinary bladder cancer	8.26e-06	4.88e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CXCL8—urinary bladder cancer	8.26e-06	4.88e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CREBBP—urinary bladder cancer	8.21e-06	4.86e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CREBBP—urinary bladder cancer	8.21e-06	4.86e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	8.21e-06	4.85e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—HRAS—urinary bladder cancer	8.2e-06	4.85e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—MYC—urinary bladder cancer	8.17e-06	4.83e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CXCL8—urinary bladder cancer	8.12e-06	4.8e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IGF1—urinary bladder cancer	8.11e-06	4.8e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IGF1—urinary bladder cancer	8.11e-06	4.8e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CXCL8—urinary bladder cancer	8.11e-06	4.79e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—EGFR—urinary bladder cancer	8.07e-06	4.77e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—EGFR—urinary bladder cancer	8.07e-06	4.77e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—HRAS—urinary bladder cancer	8.07e-06	4.77e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—EP300—urinary bladder cancer	8.06e-06	4.77e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—HRAS—urinary bladder cancer	8.05e-06	4.76e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PTGS2—urinary bladder cancer	8.04e-06	4.76e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PTGS2—urinary bladder cancer	8.04e-06	4.76e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—SRC—urinary bladder cancer	8.03e-06	4.75e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—EP300—urinary bladder cancer	8.02e-06	4.74e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—EGFR—urinary bladder cancer	7.99e-06	4.72e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—EP300—urinary bladder cancer	7.99e-06	4.72e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—EP300—urinary bladder cancer	7.99e-06	4.72e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PTEN—urinary bladder cancer	7.95e-06	4.7e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL2—urinary bladder cancer	7.89e-06	4.66e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	7.89e-06	4.66e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	7.88e-06	4.66e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—KRAS—urinary bladder cancer	7.88e-06	4.66e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—SRC—urinary bladder cancer	7.84e-06	4.64e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—SRC—urinary bladder cancer	7.8e-06	4.61e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TP53—urinary bladder cancer	7.8e-06	4.61e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—ERBB2—urinary bladder cancer	7.79e-06	4.61e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TP53—urinary bladder cancer	7.79e-06	4.6e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—SRC—urinary bladder cancer	7.77e-06	4.59e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—SRC—urinary bladder cancer	7.77e-06	4.59e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL2—urinary bladder cancer	7.76e-06	4.59e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL2—urinary bladder cancer	7.75e-06	4.58e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CCND1—urinary bladder cancer	7.69e-06	4.55e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—RHOA—urinary bladder cancer	7.68e-06	4.54e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—KRAS—urinary bladder cancer	7.62e-06	4.51e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—KRAS—urinary bladder cancer	7.62e-06	4.51e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—EGFR—urinary bladder cancer	7.62e-06	4.51e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—EP300—urinary bladder cancer	7.58e-06	4.48e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CCND1—urinary bladder cancer	7.57e-06	4.47e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CCND1—urinary bladder cancer	7.55e-06	4.46e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—KRAS—urinary bladder cancer	7.55e-06	4.46e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	7.55e-06	4.46e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	7.49e-06	4.43e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	7.48e-06	4.42e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MMP9—urinary bladder cancer	7.47e-06	4.41e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—HRAS—urinary bladder cancer	7.46e-06	4.41e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PTEN—urinary bladder cancer	7.45e-06	4.4e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—HRAS—urinary bladder cancer	7.45e-06	4.4e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CDKN1A—urinary bladder cancer	7.44e-06	4.4e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—RHOA—urinary bladder cancer	7.43e-06	4.39e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—RHOA—urinary bladder cancer	7.43e-06	4.39e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PTEN—urinary bladder cancer	7.42e-06	4.39e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CXCL8—urinary bladder cancer	7.39e-06	4.37e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—EGFR—urinary bladder cancer	7.37e-06	4.36e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—EGFR—urinary bladder cancer	7.37e-06	4.36e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MMP9—urinary bladder cancer	7.35e-06	4.34e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—HRAS—urinary bladder cancer	7.34e-06	4.34e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MMP9—urinary bladder cancer	7.33e-06	4.33e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CDKN1A—urinary bladder cancer	7.32e-06	4.33e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CDKN1A—urinary bladder cancer	7.31e-06	4.32e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PTEN—urinary bladder cancer	7.3e-06	4.32e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PTEN—urinary bladder cancer	7.29e-06	4.31e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	7.25e-06	4.29e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PTEN—urinary bladder cancer	7.25e-06	4.29e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	7.23e-06	4.28e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—KRAS—urinary bladder cancer	7.2e-06	4.26e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—MYC—urinary bladder cancer	7.2e-06	4.25e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	7.19e-06	4.25e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—ERBB2—urinary bladder cancer	7.11e-06	4.2e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—EP300—urinary bladder cancer	7.11e-06	4.2e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—EP300—urinary bladder cancer	7.08e-06	4.19e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL2—urinary bladder cancer	7.06e-06	4.18e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—EGFR—urinary bladder cancer	7.04e-06	4.16e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MYC—urinary bladder cancer	7.03e-06	4.15e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PTEN—urinary bladder cancer	7.01e-06	4.15e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PTEN—urinary bladder cancer	7.01e-06	4.15e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MYC—urinary bladder cancer	6.99e-06	4.13e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	6.97e-06	4.12e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—KRAS—urinary bladder cancer	6.97e-06	4.12e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—KRAS—urinary bladder cancer	6.97e-06	4.12e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EP300—urinary bladder cancer	6.97e-06	4.12e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—MYC—urinary bladder cancer	6.96e-06	4.12e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—MYC—urinary bladder cancer	6.96e-06	4.12e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EP300—urinary bladder cancer	6.95e-06	4.11e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—EP300—urinary bladder cancer	6.92e-06	4.09e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	6.89e-06	4.07e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	6.89e-06	4.07e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCND1—urinary bladder cancer	6.88e-06	4.07e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—SRC—urinary bladder cancer	6.88e-06	4.07e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—ERBB2—urinary bladder cancer	6.88e-06	4.07e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—ERBB2—urinary bladder cancer	6.88e-06	4.07e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—EGFR—urinary bladder cancer	6.87e-06	4.06e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—EGFR—urinary bladder cancer	6.84e-06	4.04e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—EGFR—urinary bladder cancer	6.81e-06	4.02e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—EGFR—urinary bladder cancer	6.81e-06	4.02e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—SRC—urinary bladder cancer	6.77e-06	4e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—SRC—urinary bladder cancer	6.76e-06	4e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CXCL8—urinary bladder cancer	6.74e-06	3.99e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—urinary bladder cancer	6.71e-06	3.97e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—HRAS—urinary bladder cancer	6.7e-06	3.96e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—EP300—urinary bladder cancer	6.69e-06	3.95e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—EP300—urinary bladder cancer	6.69e-06	3.95e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MMP9—urinary bladder cancer	6.68e-06	3.95e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CDKN1A—urinary bladder cancer	6.66e-06	3.94e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—KRAS—urinary bladder cancer	6.65e-06	3.93e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PTEN—urinary bladder cancer	6.65e-06	3.93e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	6.59e-06	3.9e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CXCL8—urinary bladder cancer	6.52e-06	3.86e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CXCL8—urinary bladder cancer	6.52e-06	3.86e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—KRAS—urinary bladder cancer	6.49e-06	3.84e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—HRAS—urinary bladder cancer	6.48e-06	3.83e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—HRAS—urinary bladder cancer	6.48e-06	3.83e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	6.47e-06	3.83e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—KRAS—urinary bladder cancer	6.46e-06	3.82e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	6.46e-06	3.82e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL2—urinary bladder cancer	6.44e-06	3.81e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—KRAS—urinary bladder cancer	6.43e-06	3.8e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—KRAS—urinary bladder cancer	6.43e-06	3.8e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—HRAS—urinary bladder cancer	6.42e-06	3.79e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	6.39e-06	3.78e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EP300—urinary bladder cancer	6.34e-06	3.75e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	6.31e-06	3.73e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCND1—urinary bladder cancer	6.28e-06	3.71e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL2—urinary bladder cancer	6.23e-06	3.69e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL2—urinary bladder cancer	6.23e-06	3.69e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MYC—urinary bladder cancer	6.17e-06	3.65e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—SRC—urinary bladder cancer	6.16e-06	3.64e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	6.14e-06	3.63e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HRAS—urinary bladder cancer	6.12e-06	3.62e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MMP9—urinary bladder cancer	6.1e-06	3.61e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	6.09e-06	3.6e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CDKN1A—urinary bladder cancer	6.08e-06	3.59e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCND1—urinary bladder cancer	6.08e-06	3.59e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCND1—urinary bladder cancer	6.08e-06	3.59e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MYC—urinary bladder cancer	6.07e-06	3.59e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PTEN—urinary bladder cancer	6.06e-06	3.58e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MYC—urinary bladder cancer	6.06e-06	3.58e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—EGFR—urinary bladder cancer	6.03e-06	3.57e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—EP300—urinary bladder cancer	6.02e-06	3.56e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	5.94e-06	3.51e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EGFR—urinary bladder cancer	5.94e-06	3.51e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EGFR—urinary bladder cancer	5.92e-06	3.5e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HRAS—urinary bladder cancer	5.92e-06	3.5e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HRAS—urinary bladder cancer	5.92e-06	3.5e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MMP9—urinary bladder cancer	5.9e-06	3.49e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MMP9—urinary bladder cancer	5.9e-06	3.49e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	5.89e-06	3.48e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CDKN1A—urinary bladder cancer	5.88e-06	3.48e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CDKN1A—urinary bladder cancer	5.88e-06	3.48e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PTEN—urinary bladder cancer	5.87e-06	3.47e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PTEN—urinary bladder cancer	5.87e-06	3.47e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EP300—urinary bladder cancer	5.78e-06	3.42e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—urinary bladder cancer	5.77e-06	3.41e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—urinary bladder cancer	5.74e-06	3.39e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—KRAS—urinary bladder cancer	5.7e-06	3.37e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—HRAS—urinary bladder cancer	5.65e-06	3.34e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	5.63e-06	3.33e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—SRC—urinary bladder cancer	5.62e-06	3.32e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—KRAS—urinary bladder cancer	5.61e-06	3.32e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—KRAS—urinary bladder cancer	5.6e-06	3.31e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EP300—urinary bladder cancer	5.59e-06	3.31e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EP300—urinary bladder cancer	5.59e-06	3.31e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MYC—urinary bladder cancer	5.52e-06	3.26e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—HRAS—urinary bladder cancer	5.52e-06	3.26e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—HRAS—urinary bladder cancer	5.49e-06	3.25e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—HRAS—urinary bladder cancer	5.47e-06	3.23e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—HRAS—urinary bladder cancer	5.47e-06	3.23e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—SRC—urinary bladder cancer	5.44e-06	3.22e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—SRC—urinary bladder cancer	5.44e-06	3.22e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EGFR—urinary bladder cancer	5.4e-06	3.19e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—EP300—urinary bladder cancer	5.37e-06	3.17e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	5.18e-06	3.06e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	5.13e-06	3.04e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KRAS—urinary bladder cancer	5.1e-06	3.02e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—urinary bladder cancer	5.07e-06	3e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MYC—urinary bladder cancer	5.04e-06	2.98e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	5.03e-06	2.97e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—urinary bladder cancer	4.98e-06	2.95e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—urinary bladder cancer	4.97e-06	2.94e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—EP300—urinary bladder cancer	4.94e-06	2.92e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	4.94e-06	2.92e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EGFR—urinary bladder cancer	4.93e-06	2.91e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—EP300—urinary bladder cancer	4.9e-06	2.89e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MYC—urinary bladder cancer	4.87e-06	2.88e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MYC—urinary bladder cancer	4.87e-06	2.88e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—HRAS—urinary bladder cancer	4.85e-06	2.86e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EGFR—urinary bladder cancer	4.77e-06	2.82e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EGFR—urinary bladder cancer	4.77e-06	2.82e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—HRAS—urinary bladder cancer	4.77e-06	2.82e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—HRAS—urinary bladder cancer	4.76e-06	2.81e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4.74e-06	2.8e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KRAS—urinary bladder cancer	4.66e-06	2.75e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—urinary bladder cancer	4.54e-06	2.68e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KRAS—urinary bladder cancer	4.5e-06	2.66e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KRAS—urinary bladder cancer	4.5e-06	2.66e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	4.39e-06	2.59e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—HRAS—urinary bladder cancer	4.34e-06	2.56e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—EP300—urinary bladder cancer	4.18e-06	2.47e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—urinary bladder cancer	4.14e-06	2.45e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—urinary bladder cancer	4e-06	2.37e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—urinary bladder cancer	4e-06	2.37e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HRAS—urinary bladder cancer	3.96e-06	2.34e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.88e-06	2.3e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HRAS—urinary bladder cancer	3.83e-06	2.26e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HRAS—urinary bladder cancer	3.83e-06	2.26e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.39e-06	2e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.23e-06	1.91e-05	CbGpPWpGaD
